Scarica l'app Stockscreener
31.96
5.44%
-1.84
Precedente Chiudi:
$33.80
Aprire:
$33.82
Volume 24 ore:
380.93K
Relative Volume:
1.10
Capitalizzazione di mercato:
$976.36M
Reddito:
$339.92M
Utile/perdita netta:
$-12.83M
Rapporto P/E:
-74.41
EPS:
-0.4295
Flusso di cassa netto:
$4.52M
1 W Prestazione:
-7.15%
1M Prestazione:
-9.92%
6M Prestazione:
+30.13%
1 anno Prestazione:
+41.86%
Intervallo 1D:
$31.80
$34.15
Intervallo di 1 settimana:
$31.80
$34.42
Portata 52W:
$17.72
$44.28
Castle Biosciences Inc Stock (CSTL) Company Profile
Nome
Castle Biosciences Inc
Settore
Industria
Telefono
866-788-9007
Indirizzo
1500 W. PARKWOOD AVE., FRIENDSWOOD, TX
Compare CSTL vs TMO, DHR, NTRA, A, IDXX
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
31.96 | 976.36M | 339.92M | -12.83M | 4.52M | -0.4295 |
TMO
Thermo Fisher Scientific Inc
|
690.00 | 255.13B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
229.04 | 161.01B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
393.44 | 56.71B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
172.97 | 48.77B | 7.23B | 1.41B | 1.09B | 4.979 |
IDXX
Idexx Laboratories Inc
|
560.36 | 44.15B | 4.45B | 1.10B | 1.06B | 13.59 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-06-25 | Iniziato | Roth Capital | Buy |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-01-07 | Iniziato | Stephens | Overweight |
| 2021-04-30 | Iniziato | Lake Street | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2019-12-27 | Reiterato | Canaccord Genuity | Buy |
| 2019-08-19 | Iniziato | BTIG Research | Buy |
| 2019-08-19 | Iniziato | Canaccord Genuity | Buy |
| 2019-08-19 | Iniziato | Robert W. Baird | Outperform |
| 2019-08-19 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Castle Biosciences Inc Borsa (CSTL) Ultime notizie
Form 4 Castle Biosciences Inc For: 10 October By Investing.com - Investing.com South Africa
Castle Biosciences president and CEO Derek Maetzold sells $515k stock - Investing.com
Form 4 Castle Biosciences Inc For: 10 October By Investing.com - Investing.com Nigeria
Castle Biosciences CEO Derek Maetzold Executes Option Exercise and Sells 14,496 Shares on October 5, 2026 - Kalkine Media
Castle Biosciences Officer Derek Maetzold Files Form 144 for 28,992 Share Sale Valued Over $1 Million - Kalkine Media
An officer and two trusts propose selling 28,992 shares of Castle Biosciences (CSTL). - Stock Titan
Castle Biosciences COO Kristen M. Oelschlager Exercises Stock Options and Sells Shares Under Rule 10b5-1 Plan - Kalkine Media
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 6,577 Shares - GuruFocus
Castle Biosciences CCO Executes 6,577-Share Sale Under Rule 10b5-1 Plan - Kalkine Media
Officer Kristen Oelschlager proposes selling 4,153 Castle Biosciences (CSTL) shares. - stocktitan.net
Castle Biosciences CEO sells $512k in stock - Investing.com
Form 4 Castle Biosciences Inc For: 26 September By Investing.com - Investing.com Nigeria
Castle Biosciences CEO sells $512k in stock By Investing.com - Investing.com Nigeria
Form 4 Castle Biosciences Inc For: 26 September By Investing.com - Investing.com India
Castle Biosciences (NASDAQ:CSTL) Upgraded to "Buy" at Wall Street Zen - marketbeat.com
How Investors May Respond To Castle Biosciences Stock After New Test Validation Studies - simplywall.st
Castle Biosciences (NASDAQ: CSTL) Chief Commercial Officer Juvenal Tobin W Sells 6,600 Shares Between $32.32 and $35.14 - Kalkine Media
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 6,600 Shares - GuruFocus
6,600 Castle Biosciences (CSTL) shares sold under preset 10b5-1 plan - Stock Titan
Castle Biosciences (CSTL) CCO plans more stock sales under 10b5-1 plan - Stock Titan
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Consensus Rating of "Moderate Buy" from Brokerages - marketbeat.com
Preset sale plan at Castle Biosciences (CSTL) covers 29K shares - Stock Titan
Castle Biosciences, Inc.JAAD Publication Shows Improved Performance of DecisionDx-SCC - marketscreener.com
Responsive Playbooks and the CSTL Inflection - Stock Traders Daily
Castle Biosciences, Inc. (CSTL) Stock Price Quote Today & Current Price Chart - Capital.com
JAAD Publication Shows Improved Performance of DecisionDx®-SCC - AdVantageNews.com
CSTL Looks 8.4% Overvalued on GF Value™ - GuruFocus
SciBase receives additional order from Castle Biosciences, advancing the collaboration - Yahoo Finance
Bank of New York Mellon Corp Invests $2.34 Million in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences, Inc. $CSTL Shares Sold by Bank of America Corp DE - MarketBeat
Castle Biosciences COO Oelschlager sells $138,642 in shares By Investing.com - Investing.com Nigeria
Castle Biosciences COO Oelschlager sells $138,642 in shares - Investing.com
Castle Biosciences COO Oelschlager sells $138,642 in shares - Investing.com India
Castle Biosciences COO Oelschlager sells $138,642 in shares By Investing.com - Investing.com UK
Castle Biosciences CCO Tobin Juvenal sells $51,190 in shares By Investing.com - Investing.com South Africa
Castle Biosciences (NASDAQ:CSTL) Beats Estimates As Momentum Builds - Kalkine Media
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 1,730 Shares - GuruFocus
Castle Biosciences (CSTL) Slips 2.4% to $32.62: Key Support in FocusNews Sentiment - vinanet.vn
Castle Biosciences CCO Tobin Juvenal sells $51,190 in shares By Investing.com - Investing.com India
Castle Biosciences CCO Tobin Juvenal sells $51,190 in shares By Investing.com - Investing.com Canada
Castle Biosciences CCO Tobin Juvenal sells $51,190 in shares By Investing.com - Investing.com Australia
Castle Biosciences CCO Tobin Juvenal sells $51,190 in shares - Investing.com
Empowered Funds LLC Acquires New Shares in Castle Biosciences, Inc. $CSTL - marketbeat.com
Castle Biosciences (NASDAQ: CSTL) CCO sells 1,730 shares under 10b5-1 plan - stocktitan.net
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells $412,609.60 in Stock - marketbeat.com
CSTL stock gains as institutional investor builds position and recent results support growth story - ad-hoc-news.de
CSTL Q2 2026 Earnings: Loss Narrows to -$0.07 per Share, Delivering an 83% BeatFull Year Guidance - vinanet.vn
Man Group plc Takes $2.59 Million Position in Castle Biosciences, Inc. $CSTL - MarketBeat
3,291,963 Shares in Castle Biosciences, Inc. $CSTL Purchased by BlackRock Inc. - MarketBeat
(CSTL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Castle Biosciences Inc Azioni (CSTL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Castle Biosciences Inc Azioni (CSTL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Tobin Juvenal | Chief Commercial Officer |
Oct 12 '26 |
Proposed Sale |
32.76 |
13,154 |
430,925 |
0 |
| MAETZOLD DEREK J | Pres. & Chief Exec. Officer |
Oct 05 '26 |
Option Exercise |
2.39 |
8,165 |
19,514 |
29,644 |
| MAETZOLD DEREK J | Pres. & Chief Exec. Officer |
Oct 05 '26 |
Sale |
35.57 |
8,580 |
305,156 |
21,064 |
| MAETZOLD DEREK J | Pres. & Chief Exec. Officer |
Oct 05 '26 |
Sale |
35.57 |
5,916 |
210,408 |
6,832 |
| Derek Maetzold | Officer |
Oct 05 '26 |
Proposed Sale |
36.65 |
28,992 |
1,062,557 |
0 |
| KRISTEN OELSCHLAGER | Officer |
Oct 01 '26 |
Proposed Sale |
35.53 |
4,153 |
147,556 |
0 |
| Oelschlager Kristen M | Chief Operating Officer |
Oct 01 '26 |
Option Exercise |
3.38 |
4,153 |
14,037 |
17,509 |
| Oelschlager Kristen M | Chief Operating Officer |
Oct 01 '26 |
Sale |
35.95 |
4,153 |
149,318 |
13,356 |
| Juvenal Tobin W | Chief Commercial Officer |
Sep 30 '26 |
Sale |
34.20 |
1,034 |
35,363 |
52,007 |
| Juvenal Tobin W | Chief Commercial Officer |
Sep 29 '26 |
Sale |
35.50 |
5,543 |
196,765 |
53,041 |
4.97%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):